Bruker reports three consecutive quarters of book-to-bill above 1.0 due to strong semiconductor metrology orders and overseas academic government demand. Organic revenue declined in Q1 from year-earlier comparisons but is expected to rebound in Q2. Semiconductor metrology and China are key growth drivers with AI-related and new-fab demand supporting order strength. Management cited strong order performance in Q1 and above-expected earnings at Jefferies healthcare conference. China remains a long-term growth opportunity despite local competition.
Tap to vote and see what everyone thinks.
AXT Stock Surges 5,100% as Crypto Drops 40%
Summary by ByteBrief